Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IIISAS Trial: Intravenous Iron Supplement for Iron Deficiency in Severe Aortic Stenosis
NCT04206228Phase 2Completed
- Sponsor
- Oslo University Hospital
- Start
- Jan 2020
- Primary completion
- Feb 2022
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ferric derisomaltose in iron deficiency anemia (IDA), sponsored by Oslo University Hospital. Started Jan 2020; status: completed.
02
Drugs
ferric derisomaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT04206228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04206228.